Single Cell Genomics Markets Forecasts by End User & Technology. With Executive and Consultant Guides and including Customized Forecasting and Analysis. With COVID Updates. 2021 to 2025

OVERVIEW:

Single Cell Genomics is emerging as a mainstay of scientific research and development. New life forms have already been identified. This means new diseases and new cures. There are applications in every aspect of healthcare. Just coming out of the lab it is finding its footing in new clinical applications especially related to immune-oncology and microbiology. But the largest market is still in research and the market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

ABOUT THE LEAD AUTHOR:

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research. He is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell's education includes:

• B.Sc. (Chemistry) University of BC
• M.B.A. (Finance and Policy) University of BC
• Market Research Seminar - Burke Institute
• Finance for Senior Executives - Harvard Business School

Table of Contents

i. Market Guides

• iA. Situation Analysis & COVID Update
• iB. Guide for Executives and Marketing Staff
• iC. Guide for Investment Analysts and Management Consultants

1. Introduction and Market Definition

• 1.1. What is Single Cell Genomics?
• 1.2. SCG - Still Early Days
• 1.3. Market Definition
  • 1.3.1. Market Size
  • 1.3.2. Currency
  • 1.3.3. Years
• 1.4. Methodology
  • 1.4.1. Authors
  • 1.4.2. Sources
• 1.5. Sizing the Genome - Not What You Think
  • 1.5.1. Cost, Price and Genome Size, Pricing Practice
• 1.6. GLOBAL LISTING OF HIGH THROUGHPUT SEQUENCING ESTABLISHMENTS INSTALLED BASE - Location & Contacts

2. Single Cell Genomics - Guide to Technology

• 2.1. Isolating Single Cells
  • 2.1.1. FACS
  • 2.1.2. LCM
  • 2.1.3. Micromanipulators
  • 2.1.4. Microfluidics
• 2.2. Amplification
  • 2.2.1. WTA - Whole Transcriptome Amplification
  • 2.2.2. WGA - Whole Genome Amplification
• 2.3. PCR
• 2.4. NGS
• 2.5. Microarray
• 2.6. Digital Spatial Profiling (DSP) Technology

3. Industry Overview

• 3.1. Players in a Dynamic Market
  • 3.1.1. Academic Research Lab
  • 3.1.2. Genomic Instrumentation Supplier
  • 3.1.3. Cell Separation and Viewing Instrumentation Supplier
  • 3.1.4. Cell Line and Reagent Supplier
  • 3.1.5. Pharmaceutical or Reagent Company
  • 3.1.6. Audit Body
  • 3.1.7. Certification Body

4. Market Trends

• 4.1. Factors Driving Growth
  • 4.1.1. Immuno-oncology
  • 4.1.2. Research Range
  • 4.1.3. Technology Maturity & Convergence
  • 4.1.4. Declining Costs
• 4.2. Factors Limiting Growth
  • 4.2.1. Competition
  • 4.2.2. Instrument Integration
  • 4.2.3. Technology Shift
  • 4.2.4. Technology Limitations
• 4.3. Technology Development
  • 4.3.1. Spatial Profiling
  • 4.3.2. Integration
  • 4.3.3. Big Data
  • 4.3.4. Kits and Commodities

5. Single Cell Genomics Recent Developments

• 5.1. Recent Developments - Importance and How to Use This Section
  • 5.1.1. Importance of These Developments
  • 5.1.2. How to Use This Section
    • DNTR-Seq Combines WGS, Transcriptomics in Single Cells
    • BitBiome Builds Single-Cell Bacterial Sequencing Business
    • S2 Genomics Signs Distribution Agreements for Asia-Pacific
    • Single-Cell COVID-19 Study Investigates Immune Hyperactivation
    • Levitas Bio to Launch Magnetic Levitation Cell Separation Platform
    • Single-Cell and Spatial Genomics
    • Single-Cell Genomics
    • Namocell, Takara Bio, HepaTx Partner on Single-Cell Genomics
    • Vizgen Launches With $14M Series A Financing
    • SeqWell Raises $9M in Series B Round
    • MGI Tech Introduces Portable Sequencer, Single-Cell Prep Device
    • Celsius Therapeutics to Use Single-Cell Platform in Immuno-Oncology
    • 10x Genomics Expects $271M In Proceeds
    • Celsius Therapeutics, Janssen Biotech Form Biomarker Discovery Alliance
    • Bio-Rad, 10x Genomics Claim Single-Cell Patent Fight Victories on Different Bio-Rad Launches its Single Cell scATAC-Seq Solution
    • 10x Genomics Acquires Spatial Transcriptomics
    • Takara Bio strengthens its IP position on single cell RNA-seq
    • Mission Bio Launches Tapestri® for Targeted Single-Cell DNA Custom Panels
    • SingulOmics Detects Somatic Single Nucleotide Variations in Single Cells
    • 1CELLBIO and OMI to validate Single Cell Analysis for Personalized Medicine
    • Sony MA900 Cell Sorter Nominated
    • UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV Diagnostic Assay
    • Bio-Rad's dd-PCR tests for leukemia cleared
    • IncellDx's Single Cell Immuno-Oncology/PD-L1 Technology used in new Cancer Assay Cytena GmbH land EUR 3M in Series A
    • NanoString Announces Launch of CAR-T Panel
    • Dolomite Bio launches high throughput single nuclei profiling on Nadia platform
    • Silicon Biosystems Develops New Assay for Circulating Multiple Myeloma Cells

6. Profiles of Key Single Cell Genomics Companies

• 10x Genomics
• 1CellBio
• Agilent
• Beckman Coulter
• Becton Dickinson
• Bio-Rad
• Bitbiome
• Bruker
• Cell Microsystems
• Cellsee Diagnostics
• CellSorter
• Cytena
• CytoTrack
• Dolomite Bio
• Fluidigm
• Fluxion Biosciences
• Illumina
• IncellDx
• Labcyte
• Leica Microsystems
• Miltenyi Biotec
• Mission Bio
• Oxford Nanopore Technologies
• NanoString
• Perkin Elmer
• Qiagen
• Readcoor
• S2 Genomics
• Silicon Biosystems
• Singulomics
• Sony
• Takara Bio
• Thermo Fisher
• Watchmaker Genomics

7. Single Cell Genomics Global Market Size

• 7.1. Global Market Overview by Country
  • 7.1.1. Table - Global Market by Country
  • 7.1.2. Chart - Global Market by Country
• 7.2. Global Market Size by Technology - Overview
  • 7.2.1. Table - Global Market by Technology
  • 7.2.2. Chart - Global Market by Technology - Base/Final Year Comparison
  • 7.2.3. Chart - Global Market by Technology - Base Year
  • 7.2.4. Chart - Global Market by Technology - Final Year
  • 7.2.5. Chart - Global Market by Technology - Share by Year
  • 7.2.6. Chart - Global Market by Technology - Segment Growth
• 7.3. Global Market End User - Overview
  • 7.3.1. Table - Global Market End User
  • 7.3.2. Chart - Global Market End User - Base/Final Year Comparison
  • 7.3.3. Chart - Global Market End User - Base Year
  • 7.3.4. Chart - Global Market End User - Final Year
  • 7.3.5. Chart - Global Market End User - Share by Year
  • 7.3.6. Chart - Global Market End User - Segment Growth

8. Global Market by Technology

• 8.1. PCR Market
  • 8.1.1. Table - PCR Market by Country
  • 8.1.2. Chart - PCR Market by Country
• 8.2. qPCR Market
  • 8.2.1. Table - qPCR Market by Country
  • 8.2.2. Chart - qPCR Market Growth
• 8.3. NGS Market
  • 8.3.1. Table - NGS Market by Country
  • 8.3.2. Chart - NGS Market Growth
• 8.4. Microarray Market
  • 8.4.1. Table - Microarray Market by Country
  • 8.4.2. Chart - Microarray Market Growth
• 8.5. Other Technology Market
  • 8.5.1. Table - Other Technology Market by Country
  • 8.5.2. Chart - Other Technology Market Growth

9. Single Cell Genomics Market by End User

• 9.1. Research Market
  • 9.1.1. Table - Research Market by Country
  • 9.1.2. Chart - Research Market Growth
• 9.2. BioPharma Market
  • 9.2.1. Table - BioPharma Market by Country
  • 9.2.2. Chart - BioPharma Market Growth
• 9.3. Clinical Market
  • 9.3.1. Table - Clinical Market by Country
  • 9.3.2. Chart - Clinical Market Growth
• 9.4. Other End User Market
  • 9.4.1. Table - Other End User Market by Country
  • 9.4.2. Chart - Other End User Market Growth

10. Appendices

• 10.1. FDA Cancer Drug Approvals by Year
• 10.2. Clinical Trials Started 2010 to 2016
• 10.3. Prevalence of Cancer Treatments

Table of Tables

• Table 1: Global List of Gene Sequencing Facilities
• Table 2: Cell Isolation Overview
• Table 3: Market Players by Type
• Table 4: Five Factors Driving Growth
• Table 5: Three Factors Limiting Growth
• Table 6: Single Cell Genomics Global Market by Country/Region
• Table 7: Single Cell Genomics Global Market by Technology
• Table 8: Global Market End User
• Table 9: PCR Market by Country
• Table 10: qPCR Market by Country
• Table 11: NGS Market by Country
• Table 12: Microarray Market by Country
• Table 13: Other Technology Market by Country
• Table 14: Research Market by Country
• Table 15: BioPharma Market by Country
• Table 16: Clinical Market by Country
• Table 17: Other End User Market by Country

Table of Figures

• Figure 1: Size of Different Genomes
• Figure 2: flourescence Activated Sorter
• Figure 3: Market Size by Country
• Figure 4: Global Market by Technology - Base vs. Final Year
• Figure 5: Technology Market Base Year
• Figure 6: Technology Market Final Year
• Figure 7: Technology Share by Year
• Figure 8: Technology Segment Growth
• Figure 9: End User - Base vs. Final Year
• Figure 10: End User Market Base Year
• Figure 11: End User Market Final Year
• Figure 12: End User Share by Year
• Figure 13: End User Segment Growth
• Figure 14: Chart - PCR Market Growth
• Figure 15: Chart qPCR Market Growth
• Figure 16: Chart - NGS Market Growth
• Figure 17: Chart - Microarray Market Growth
• Figure 18: Chart - Other Technology Market Growth
• Figure 19: Chart - Research Market Growth
• Figure 20: Chart - BioPharma Market Growth
• Figure 21: Chart - Clinical Market Growth
• Figure 22: Chart - Other End User Market Growth
• Figure 23: FDA Cancer Drug Approvals by Year
• Figure 24: Clinical Trials for Immunotherapy by Year
• Figure 25: Pie Chart of Prevalence of Cancer Treatments